CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥3,711,455 | ¥4,355,063 | ¥4,510,544 | ¥4,273,829 |
| % Growth | -14.8% | -3.4% | 5.5% | – |
| Cost of Goods Sold | ¥1,623,978 | ¥1,937,651 | ¥1,326,000 | ¥1,209,528 |
| Gross Profit | ¥2,087,477 | ¥2,417,412 | ¥3,184,544 | ¥3,064,301 |
| % Margin | 56.2% | 55.5% | 70.6% | 71.7% |
| R&D Expenses | ¥0 | ¥71,009 | ¥72,453 | ¥87,562 |
| G&A Expenses | ¥0 | ¥290,750 | ¥302,430 | ¥324,047 |
| SG&A Expenses | ¥1,920,768 | ¥395,813 | ¥406,323 | ¥425,481 |
| Sales & Mktg Exp. | ¥0 | ¥105,063 | ¥103,893 | ¥101,434 |
| Other Operating Expenses | ¥0 | ¥1,821,432 | ¥1,484,721 | ¥980,200 |
| Operating Expenses | ¥1,920,768 | ¥2,288,254 | ¥1,963,497 | ¥1,493,243 |
| Operating Income | ¥166,709 | ¥129,158 | ¥1,221,499 | ¥1,571,052 |
| % Margin | 4.5% | 3% | 27.1% | 36.8% |
| Other Income/Exp. Net | -¥56,863 | ¥165,783 | ¥18,183 | ¥12,587 |
| Pre-Tax Income | ¥109,846 | ¥294,941 | ¥1,239,682 | ¥1,583,639 |
| Tax Expense | ¥99,186 | ¥57,000 | ¥316,540 | ¥565,796 |
| Net Income | ¥10,659 | ¥237,940 | ¥923,142 | ¥1,017,842 |
| % Margin | 0.3% | 5.5% | 20.5% | 23.8% |
| EPS | 0.54 | 12.01 | 48.88 | 54.54 |
| % Growth | -95.5% | -75.4% | -10.4% | – |
| EPS Diluted | 0.54 | 11.96 | 47.93 | 52.98 |
| Weighted Avg Shares Out | 19,814 | 19,802 | 18,884 | 18,662 |
| Weighted Avg Shares Out Dil | 19,894 | 19,903 | 19,260 | 19,213 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥251 | ¥48 | ¥13 | ¥7 |
| Interest Expense | ¥1,314 | ¥1,362 | ¥379 | ¥11 |
| Depreciation & Amortization | ¥204,319 | ¥153,226 | ¥66,376 | ¥61,148 |
| EBITDA | ¥315,480 | ¥449,530 | ¥1,306,440 | ¥1,644,798 |
| % Margin | 8.5% | 10.3% | 29% | 38.5% |